Jatenzo
Payments companies reported to CMS as associated with Jatenzo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Jatenzo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Jatenzo
These are the largest totals companies reported as associated with Jatenzo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Adrian Dobs | Baltimore, MD | Endocrinology, Diabetes & Metabolism | $12,895.22 |
| Alan Rogol | Charlottesville, VA | Pediatrics | $8,693.75 |
| Sandeep Dhindsa | Saint Louis, MO | Endocrinology, Diabetes & Metabolism | $8,289.54 |
| Joshua Calvert | Nashville, TN | Urology | $5,804.12 |
| Kevin Donohue | Falls Church, VA | Internal Medicine | $3,221.81 |
| Reema Habiby | Chicago, IL | Pediatric Endocrinology | $1,060.00 |
| Peter Veneziano | Chestnut Hill, MA | Physician Assistant | $1,051.23 |
| Nora Kurbaj | Beverly, MA | Physician Assistant | $985.22 |
| Jeffrey Woods | Nashville, TN | Family | $868.22 |
| Aniket Chakrabarti | Marshfield, MA | Internal Medicine | $748.79 |
Prescribed Jatenzo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.